To Top

Search By Topic

Innovation

371 Articles available

Novel Therapy

Novel Combination Therapy Promotes Wound Healing

PR-M10-18-NI-096

Roundtable

Q: What Innovative Technologies Had the Greatest Impact on your Company this Year? What Were the Impacts?

PAP-Q4-18-NI-007

Roundtable

Q: Looking Forward, What New Technologies/Paradigms Do You Anticipate Having the Greatest Impact Next Year (Digitalization and Industry 4.0, Serialization, etc.)?

PAP-Q4-18-NI-003

3D Imaging

Tissue Analytics Launches 3D Wound Imaging for Smartphones

PR-M10-18-NI-045

Patent

Zynex Obtains U.S. Patent for Blood Volume Monitor

PR-M10-18-NI-044

Innovation

Shining a Light on Depression - How Infrared Light Can Treat Depression

PR-M10-18-NI-030

Partnership

Stryker's Advanced Guidance Technologies Announces Partnerships with Synaptive Medical and Ziehm Imaging

PR-M10-18-NI-026

Speed to Market

Product and Service Concepts Driving Speed to Market

PAO-M10-18-CL-001

Next-Generation

FDA Authorizes First Next Generation Sequencing-Based Test

PR-M10-18-NI-021

Press Releases

NeuroAiD combined with rehabilitation has shown additive and sustained benefits on post-stroke recovery

Organic Electronics

International Center for Materials Nanoarchitectonics eBulletin: Next Generation Innovative Organic Electronics

PR-M10-18-NI-018

Innovation

FDA Approves a New Antibacterial Drug to Treat a Serious Lung Disease Using a Novel Pathway to Spur Innovation

PR-M10-18-NI-016

Chromatography

Accelerating Time to Market with Integrated Preparative Chromatography Support

PAP-Q3-18-CL-010

Launch

Boston Scientific Launches LithoVue Empower™ Retrieval Deployment Device

PR-M09-18-NI-094

Robotics

$28.77 Billion Medical Robots Market to 2025 - Evolution of Nanorobots In Cancer Treatment & Increased Preferences of Patient For Robotic Surgeries

PR-M09-18-NI-090

Research

New Evidence Suggests the Brain and Stomach are in Direct Communication

PAO-M09-18-NI-023

Cell and Gene Therapy

Gene that Helps Cells Resist Zika Infection Identified

PAO-M09-18-NI-018

Synthetic Biology

Synthetic Biology Making Strides in Key Applications, Finds IDTechEx

PR-M09-18-NI-076

FDA Approval

Latest Apple Watch Gets FDA Approval as a Class II Device

PAO-M09-18-NI-012

IPO

Ophthalmic Drug Developer Kodiak BioSciences Files for IPO

PAO-M09-18-NI-010

CRISPR

CRISPR is Helping Dogs with Muscular Dystrophy and Young Boys Could be Next

PAO-M08-18-NI-030

Clinical Data

Novartis Reports Promising Results for its New Alpha Specific PI3K Inhibitor BYL719

PAO-M08-18-NI-028

FDA Approval

AbbVie Receives FDA Approval for IMBRUVICA® Plus Rituximab as a Blood Cancer Treatment

PAO-M08-18-NI-027

Research

Researchers Make Discovery about Leptin Resistance

PAO-M08-18-NI-025

Fill-Finish

Meeting the Changing Demands for Sterile-Fill Finish Operations

PAO-08-18-CL-002

FDA

Brainsway’s Transcranial Magnetic Stimulation System Gets FDA Clearance

PAO-M08-18-NI-019

Breakthrough Therapy

Xolair Gets Breakthrough Therapy Designation from US FDA for Treatment of Food Allergies

PAO-M08-18-NI-016

Market Intelligence

Forces Driving Growth in the U.S. Surgical Microscopes Market

PAO-08-18-CL-001

CRO

From Internal Lab to External Service Provider

PAO-M08-18-NI-009

Drug Delivery

Exosomes Explored as New Option in Drug Delivery

PAO-M08-18-NI-008

Microbiome

New Collaboration Targets Drug Development Using the Gut Microbiome

PAO-M08-18-NI-007

CapsCanada

Building a Robust Supply Chain with Dependable Quality Primary Suppliers

PAO-M07-18-CL-001

Research

Researchers Are One Step Closer to Developing Eye Drops to Treat Age-related Macular Degeneration (AMD)

PR-M07-18-NI-066

Clinical Data

Pulmatrix Announces Positive Top-Line Preliminary Results from Part 3 of the 3-Part Phase 1/1b Clinical Trial of Pulmazole

PR-M07-18-NI-058

Research

IDTechEx Research: Long Term In Vivo Performance of Tissue Engineered Heart Valves

PR-M07-18-NI-057

Clinical Research

Eating Well Might Improve Cancer Treatments

PAO-M07-18-NI-006

Investment

Organ-on-a-Chip Company Raises $36 Million

PAO-M07-18-NI-005

Innovation

Distek, Inc. Releases the PrepEngine Mini Sample Prep Station

PR-M06-18-NI-096

Drug Delivery

Automated Insulin Delivery System Approved for Use by More Pediatric Patients

PAO-M06-18-NI-023

Microbiome

Kaleido Raises More Money for Development of Microbiome-Based Therapeutics

PAO-M06-18-NI-021

Antiviral

Progress on New Antiviral Drugs at Chimerix

PAO-M06-18-NI-019

CAR-T Therapy

Cellectic CAR-T Therapy Contains Safety Switch and More

PAO-M06-18-NI-017

Clinical Data

New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication

PR-M06-18-NI-030

Strategic Partnership

Partnerships Between Bayer and DoE Formed to Produce Radioactive Pharma Intermediate

PAO-M06-18-NI-003

Market Expansion

BluePrint Medicines Targets Asian Market

PAO-M06-18-NI-002

Oncology

Loxo Oncology Reports Positive Results for Second Targeted Cancer Therapy

PAO-M06-18-NI-001

R&D

Researchers Find Link between Tuberculosis and Parkinson’s Disease

PAO-M05-18-NI-025

Integration

Strengthening the Outsource Service Offering through Integration

PAP-Q2-18-CL-013

Fast Track

Valneva Receives Fast Track Designation for Lyme Disease Vaccine

PAO-M05-18-NI-021

Clinical Supply

Oncternal Announces Clinical Supply Arrangement to Evaluate the Combination of Cirmtuzumab and Ibrutinib in B-cell Malignancies

PR-M05-18-NI-108

Novel Medicine

WuXi Laboratory Testing Division: Propelling Innovation and Better Treatments for Patients

PAO-M05-18-CL-004

Drug Discovery

RNA-Modifying Proteins May Provide New Drug Targets

PAO-M05-18-NI-018

Drug Development

Bacteria in the Stomach Found to Play a Role in Multiple Sclerosis

PAO-M05-18-NI-016

FDA Approval

FDA Approves New Migraine Treatment

PAO-M05-18-NI-014

Cell and Gene Therapy

Editas Founders Start New Gene Editing Company

PAO-M05-18-NI-011

Drug Development

Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis

PR-M05-18-NI-060

CRISPR

CRISPR Gene Editing Technology Could Eliminate the Need for Hemophilia B Sufferers to Receive Ongoing Injections

PAO-M05-18-NI-007

Strategic Partnership

Roche Expands Partnership with 4D Molecular Therapeutics to Treat Night Blindness

PAO-M05-18-NI-001

Drug Development

BIOCAD: Interleukin-17 Inhibitor Shows High Efficacy After One Year of Therapy in Psoriasis Patients

PR-M04-18-NI-003

Diagnostics

Development of Blood Tests for Early Cancer Detection May Be Possible

PAO-M04-18-NI-020

FDA

FDA authorizes new use of test, first to identify the emerging pathogen Candida auris

PR-M04-18-NI-93

Innovation

Pear Therapeutics and Sandoz Announce Deal to Commercialize Prescription Digital Therapeutics

PR-M04-18-NI-81

Cardiovascular

Janssen Announces Worldwide Development and Commercialization Collaboration with Bristol-Myers Squibb to Advance a Next-Generation Therapy for Cardiovascular Diseases

PR-M04-18-NI-72

Press Releases

RightBio Metrics Receives Innovative Technology Contract from Vizient, Inc. for RightSpotpH® Indicators

Immunotherapy

Immunotherapy Prior to Surgery Shows Promise in Fight Against Lung Cancer

PAO-M04-18-NI-016

Innovation

Robotic Microscope Used for Brain Surgery

PAO-M04-18-NI-014

Innovation

Swiss Advanced Vision Launches Active Intraocular Lens Concept with Real-Time Autofocus for Cataract Surgery

PR-M04-18-NI-47

NDA

Dr. Reddy's Laboratories and its U.S. subsidiary Promius Pharma announce the filing of an NDA for its migraine candidate

PR-M04-18-NI-019

Approval

Amgen Gets Expanded Approval for Blincyto®

PAO-M04-18-NI-005

Radio-Conjugates

Companies Join Forces to Develop Novel Radio-Conjugates

PAO-M04-18-NI-002

Innovation

Aditlys Creates a Natural Tissue-Growing Implant to Treat Patients Suffering from Chronic Kidney Disease

PR-M04-18-NI-009

Innovation

Spinal Resources, Inc.® Announces First Implantation with Swedge™ Pedicle Screw System

PR-M04-18-NI-008

Innovation

VICAM Introduces a New Method for BPA Detection

PR-M04-18-NI-004

HIV

Mylan Introduces Symfi™ Triple Combo Once-Daily HIV Treatment in the U.S.

PR-M03-18-NI-111

Oncology

Outcome Health And The Colorectal Cancer Alliance Announce Campaign To Support Patient Education

PR-M03-18-NI-109

Clinical Data

Phase III data in The Lancet show Novartis siponimod significantly improved outcomes in patients with secondary progressive MS

PR-M03-18-NI-095

Blockbuster

Pace of Pharmaceutical Innovation Accelerates as Record Number of New Blockbuster Drugs Forecast to Hit the Market in 2018

PR-M03-18-NI-092

Discovery

New ALS Gene Discovered: KIF5A

PR-M03-18-NI-091

Cannibis

Medical Marijuana Moves to the Big Time

PAO-M03-18-NI-019

Vaccine

Shingrix Vaccine Available at CVS

PAO-M03-18-NI-018

Innovation

Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation

PR-M03-18-NI-077

Anti-Aging

Additional Funding for Unity’s First Human Clinical Study

PAO-M03-18-NI-016

Press Releases

Thermo Fisher Scientific Showcases New Solutions for Accelerating, Innovating and Enhancing Productivity in the Fab and Lab at SEMICON China 2018

PR-M03-18-NI-060

Artificial Intelligence

Smartphone-based Retinal Imaging Together With Artificial Intelligence Powers Automated, Sensitive and Early Detection of Retinopathy

PR-M03-18-NI-052

Innovation

Evotec and Sanofi in Exclusive Talks to Create an Evotec-Led Infectious Disease Open Innovation R&D Platform

PR-M03-18-NI-047

Strategic Collaboration

Driving Change in the Pharma Industry and Biotech One Relationship at a Time

PAP-Q1-18-CL-004

Formulation

Investing in New Technologies for Innovative Functional Solutions

PAP-Q1-18-CL-009

Death to Cleanrooms in Biopharmaceutical Manufacturing

PAP-Q1-18-CL-006

Fermentation

Focused on Fermentation

PAP-Q1-18-CL-007

Press Releases

Dell Boomi, Nalta.com and digitalAngel partner to revolutionise the future of healthcare

PR-M03-18-NI-034

Digital

Novartis in Collaboration to Develop Software Applications

PAO-M03-18-NI-006

Healthcare

Orion Health Unveils New Predictive Intelligence Using Machine Learning to Help Save Billions in Healthcare Costs

PR-M03-18-NI-032

Innovation

Results of Landmark Wearable Defibrillator Trial to Be Presented as ACC.18 Late-Breaker

PR-M03-18-NI-026

Acquistion

Bruker Gains Access to QCL Technology with IRM2 Acquisition

PAO-M03-18-NI-004

Artificial Intelligence

Philips launches AI platform for healthcare

PR-M03-18-NI-016

Oncology

Charles River Laboratories Announces New Online Tool

PAO-M03-18-NI-003

Innovation

Thermo Fisher Supplies Analytical Instruments to World Anti-Doping Agency Laboratory in South Korea

PR-M03-18-NI-011

Innovation

Thermo Fisher Scientific Innovations Offer Greater Connectivity and Ease of Use

PR-M03-18-NI-005

Drug Development

Amgen Receives Positive Opinion Expanding Use Of XGEVA® (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe

PR-M02-18-NI-102

Strategic Collaboration

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

PR-M02-18-NI-93

Acquisition

Roche Pays $1.9 Billion to Acquire Flatiron Health

PAO-M02-18-NI-021

Robotics

Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics

PR-M02-18-NI-91

Influenza

GSK presents new efficacy data for FLUARIX® QUADRIVALENT (Influenza Vaccine) in children 6 months through 35 months of age

PR-M02-18-NI-87

Clinical Trials

Aimmune’s AR101 Meets Phase 3 Endpoints

PAO-M02-18-NI-020

Oncology

Device Plus Drug Approved for Bladder Cancer Detection

PAO-M02-18-NI-018

Drug Development

Evotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge

PR-M02-18-NI-79

Clinical Trials

Breakthrough Scar Treatment in Clinical Trials

PAO-M02-18-NI-016

FDA

Ortho Dermatologics Announces U.S. FDA Filing Acceptance For JEMDEL™ Plaque Psoriasis Treatment

PR-M02-18-NI-75

Approval

Celltrion Receives EU Approval for Trastuzumab Biosimilar

PR-M02-18-NI-71

Approval

The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology

PR-M02-18-NI-65

Priority Review

U.S., EU and Japan Health Authorities Accept Regulatory Submissions for Review of Pfizer’s Third-Generation ALK Inhibitor Lorlatinib

PR-M02-18-NI-52

Generics

The Path Toward Generics: 2017’s Record-Breaking Year

PAO-M02-18-NI-015

Drug Development

WuXi Biologics Congratulates Tychan for Dosing First Patient of a Zika Antibody after Record 9 Months of Development

PR-M02-18-NI-049

Drug Development

AbbVie receives a positive recommendation from the CADTH Canadian Drug Expert Committee for MAVIRET™

PR-M02-18-NI-044

Innovation

Takeda Announces Publication of Study Utilizing State-of-the-Art Modeling to Better Understand Optimal Treatment Positioning for Patients with Ulcerative Colitis

PR-M02-18-NI-042

Vaccine

First vaccine carrier approved by World Health Organization to prevent vaccine freezing during transport commercially available

PR-M02-18-NI-041

Award

Thermo Fisher Scientific Wins CiteAb 2018 Award for its Antibody Validation Initiative

PR-M02-18-NI-040

Joint Venture

DSM and Evonik Establish Veramaris Joint Venture

PR-M02-18-NI-024

Innovation

Thermo Fisher Scientific Receives Manufacturing Leaders' Innovation Award

PR-M02-18-NI-023

Healthcare

Leading Companies Taking Action to Address Healthcare

PAO-M02-18-NI-005

Animal Nutrition

Versamaris JV Formed by DSM and Evonik

PAO-M02-18-NI-004

Biosimilars

Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®

PR-M01-18-NI-092

Licensing

Grace Licenses UNIPOL® PP Process Technology to Grupa Azoty in Poland

PR-M01-18-NI-090

Strategic Partnership

WuXi Partners with Swedish Firm to Establish New Contract Manufacturer

PAO-M01-18-NI-043

Cell and Gene Therapy

Cell Therapy Companies Can Now Have Improved Cell Thawing Capabilities

PAO-M01-18-NI-042

Drug Discovery

X-Chem Enters Expanded Global Drug Discovery and Technology Transfer Collaboration with AstraZeneca

PR-M01-18-NI-073

Clinical Trial

Amgen and Novartis Reach an Important Milestone

PAO-M01-18-NI-041

Launch

GSK Launches Three-in-One HIV Pill in China

PAO-M01-18-NI-040

Symposium

Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Metastatic Colorectal Cancer (mCRC) Data at ASCO 2018 Gastrointestinal Cancers Symposium

PR-M01-18-NI-080

Clinical Data

First-Time Data for Merck’s KEYTRUDA® (pembrolizumab) in Patients with Previously Treated Advanced Hepatocellular Carcinoma (HCC) to be Presented at 2018 ASCO GI Symposium

PR-M01-18-NI-079

Approval

LYNPARZA® (olaparib) Receives Approval in Japan for the Treatment of Advanced Ovarian Cancer

PR-M01-18-NI-078

Biosimilar

European Commission Approves Amgen And Allergan's MVASI® (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer

PR-M01-18-NI-077

Opadry System

Colorcon, Inc. Transforms the Sugar Coating Process with a New Opadry System

PR-M01-18-NI-071

Strategic Collaboration

NeuroMetrix and GlaxoSmithKline Consumer Healthcare Announce Strategic Collaboration to Develop and Expand Access to Quell Wearable Pain Relief Technology

PR-M01-18-NI-075

FDA Approval

FDA to Expand the Use of Gilotrif

PAO-M01-18-NI-038

Launch

Roche launches CE-marked VENTANA MMR IHC Panel for patients diagnosed with colorectal cancer

PR-M01-18-NI-068

Technology

Thermo Fisher Scientific Announces More Than 30 Orders for Ion GeneStudio S5 One Week After Debut

PR-M01-18-NI-067

Research

Lustgarten Foundation Awarded $22 Million For Pancreatic Cancer Research

PR-M01-18-NI-066

Innovation

Harvard Researchers Use Chip Technology to Investigate New Anti-inflammatory Drugs

PAO-M01-18-NI-034

Launch

DSM Sinochem Pharmaceuticals successfully launches Rosuvastatin finished dosage formulation in Western Europe

PR-M01-18-NI-054